ValuentumAd

Official PayPal Seal
Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Jun 14, 2019
Broadcom Plummets After Cutting Guidance
Image Source: Florian Knodt. Broadcom resets investor expectations, sending shares of the company and peers lower. Broadcom sports a juicy yield.
Jun 13, 2019
RYAM: Terrible Business, Potentially Cheap Stock
Image Source: First-Quarter 2019 Presentation Materials. Rayonier Advanced Materials has seen better days, but has the market overreacted? We don’t think there are many businesses that have poorer industry structure, but if the company can get things back on track, normalized free cash flow indicates substantial upside potential. Commodity prices and tariffs remain big wild cards to this story, and the Valuentum investor always waits for technicals and momentum indicators to turn decidedly positive first.
Jun 7, 2019
Exact Sciences: Great Company But Most of the Upside Is Behind It
Image Source: Exact Sciences Corp -- IR Presentation. Exact Sciences operates as a molecular diagnostics company built around its Cologuard offering, which was approved by the US FDA in August 2014. While Exact Sciences stock has performed very well since 2016, the risk-reward trade off isn’t great as things stand today now that shares have zoomed from the single-digits in 2016 to roughly $105 per share as of this writing.
Jun 5, 2019
Dollar General Continues to Lead
Image Source: Dollar General (IR 2016 Presentation). We like Dollar General’s growth trajectory (as it plans to continue expanding its small-box store footprint via new stores) and its impressive same-store sales performance, with 29 consecutive years of growth as of fiscal 2018.
Jun 4, 2019
VBI 9-Rated AmerisourceBergen Now On Our Radar
Image Source: AmerisourceBergen Corpration -- IR Presentation. Let's take a look at VBI 9-rated stock AmerisourceBergen, a pharmaceutical sourcing and distribution company that yields 2% as of this writing. We like AmerisourceBergen's dividend growth story, strong free cash flow generation, guidance raise, and relatively low net debt load. We'll also cover AmerisourceBergen's downside risks as well as its upside potential. Shares appear undervalued as things stand today, with ABC trading below the low end of our fair value estimate range.
Jun 3, 2019
Now a Trade War on Multiple Fronts!
“To complicate matters further, President Trump also announced that he is looking to tariffs on Mexico if the country doesn’t take steps to stop the flow of illegal immigration. The US is now fighting a trade war on two fronts.” – Brian Nelson, CFA
May 31, 2019
Mall Retail Armageddon?
We think investors should be extremely cautious if they are interested in any mall retailers. Mall REITs are starting to feel some of the pain, too.
May 28, 2019
From Nano Cap to Big Cap in Biotech
Image shown: Athersys' MultiStem therapy can improve the lives of millions of stroke victims.We cover some very interesting technologies in this piece, from a nano-cap company that could best be described as a call option, a stroke therapy firm that may improve the lives of millions, to a big cap genomic sequencing leader that has exposure to the development of a liquid biopsy test for cancer.
May 24, 2019
Investors Are Paying a Hefty Premium for NextEra Energy’s Great Dividend Growth Story
Image Source: NextEra Energy -- IR Presentation.As the world slowly shifts towards a greener future, one powered by wind farms and solar plants that are supported by enormous battery facilities to ensure customers can receive power without interruption, NextEra Energy is well-positioned to capitalize on the future of electric power.
May 21, 2019
Subscribe -- Limited # Remaining for Exclusive, Retail Reports as Expected
The Exclusive publication is limited to only 1,000 members. Make sure that you reserve your spot. You receive one income idea, one capital appreciation idea, and one short-idea consideration in each monthly edition. Ideas mentioned by ticker symbol: AZO, HD, JCP, KSS, TJX.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.